Generex Biotechnology Corporation has announced publication of a follow-up study from a Phase I clinical trial of the immunotherapeutic agent AE37 in patients with prostate cancer. The study demonstrates an association between a specific immune response generated by AE37 and improved overall survival.
A prior study showed that AE37-immunized patients had better overall and disease-free survival as a group than would be expected from their disease status and the current study shows that patients with the strongest immunological response did the best. In particular, both the presence of AE37-induced T cells in peripheral blood as well as a robust delayed type hypersensitivity (DTH) response elicited by AE37 correlated significantly with overall survival.
The authors point out the importance of CD4+ T cells in developing a good DTH response. AE37 was developed using the Antigen Express Ii-Key technology platform that ensures robust, specific CD4+ T cell activation.
The current report expands upon prior studies on the results of a Phase I trial of AE37 in patients with prostate cancer.
AE37 is also the subject of a controlled, randomized Phase II trial to prevent recurrence in patients who have had breast cancer. That study has shown an encouraging trend toward preventing relapse, particularly in patients with low levels of HER2 expression and in triple negative patients. The search for reliable biomarkers is a key priority in the emerging field of cancer immunotherapy.
Article: "AE37 peptide vaccination in prostate cancer: identification of biomarkers in the context of prognosis and prediction," Cancer Immunology, Immunotherapy July 23, 2014.
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Can A New Rule Trigger A Second EU Referendum? Petition Signatures Over 8% Of Total Votes Cast
- How A Former Naturopath Can Help Unravel The Trickery of Alternative Medicine
- Beneficial Bacteria May Protect Breasts From Cancer
- Better Brains With Beer
- Finding All-Hadronic Top - Again
- Cross Talk Between Hormone Receptors Has Unexpected Effects
- Small Brain -- Astounding Performance
- "I see the actions as no different than the group that promoted the California Bond issue for Stem..."
- "I don't understand the problem. The drug side effects are a true telling of what researchers have..."
- "Seeing oneself foremost as a citizen of the country founded by one's ancestors is hardly a problem..."
- "If Puerto Rico had a $2 trillion economy, 5% unemployment, and the ability to lose $10 billion..."
- "Crystal clear writing, as usual. I thought I may have detected the same writing style in amongst..."
- Chemistry Can Help Roast the Perfect Coffee Bean
- What Happens To A Soccer Player’s Brain After Missing A Penalty Kick
- It’s Back to Shots for Flu Prevention
- ACSH Applauds Media Awareness of the Fentanyl Crisis
- Counting Bites Examined, to Help Decrease Food Intake
- The Safe And Unsafe Nutty Treats For Your Pup
About Us |